Want to see TBRG full AI Analyst Report?
TBRG Stock Chart & Stats
$23.25
$0.37(1.79%)
At close: 4:00 PM EST
$23.25
$0.37(1.79%)
Day’s Range― - ―
52-Week Range$13.88 - $26.51
Previous CloseN/A
Volume56.50K
Average Volume (3M)110.38K
Market Cap
$393.58M
Enterprise Value$524.67M
Total Cash (Recent Filing)$35.42M
Total Debt (Recent Filing)$168.46M
Price to Earnings (P/E)89.3
Beta1.07
Next Earnings
Aug 06, 2026EPS Estimate
0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding14,999,136
10 Day Avg. Volume98,314
30 Day Avg. Volume110,375
Financial Highlights & Ratios
PEG Ratio-0.63
Price to Book (P/B)1.80
Price to Sales (P/S)0.92
P/FCF Ratio8.97
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue1.52
Enterprise Value/Gross Profit2.96
Enterprise Value/Ebitda16.11
Forecast
1Y Price Target
$23.95Price Target Upside3.01% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)2.67
Revenue Forecast (FY)$355.07M
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSustained operating and free cash flow near $45M TTM provides durable internal funding for operations, product investment, and working capital. This cash conversion reduces dependence on external capital, supports resilience through cycles, and underpins strategic execution over months.
Material DeleveragingNear-elimination of leverage materially lowers financial risk and interest burden, giving management optionality. Low debt enhances the company's ability to invest in product development, cushion revenue volatility, and pursue strategic actions without servicing large debt loads.
Strategic Merger Enhances ScaleThe agreed all-cash acquisition and strategic combination with IKS creates a larger, AI-enabled health-tech provider focused on rural/community hospitals. Combined product breadth and scale can deepen customer relationships and enable cross-sell of data-driven workflows over the medium term.
Bears Say
Weak Revenue MomentumA persistent ~27% YoY revenue decline undermines growth optionality and makes scaling unit economics harder. Shrinking topline strains margin recovery, limits cross-sell opportunities, and increases reliance on cost controls or nonrecurring gains to sustain reported profits.
Thin ProfitabilityVery low operating and net margins leave little buffer for cost inflation, slower collections, or project overruns. Low ROE (~2.5%) signals the asset base is not generating strong returns, constraining reinvestment capacity and making earnings sensitive to modest revenue swings.
Deal Closing UncertaintyThe strategic outcome hinges on shareholder and remaining closing conditions; if delayed or not approved, management distraction, customer uncertainty, and integration plans could be disrupted. This creates execution and timing risk during the coming months.
TruBridge News
TBRG FAQ
What was TruBridge’s price range in the past 12 months?
TruBridge lowest stock price was $13.88 and its highest was $26.51 in the past 12 months.
What is TruBridge’s market cap?
TruBridge’s market cap is $393.58M.
When is TruBridge’s upcoming earnings report date?
TruBridge’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.
How were TruBridge’s earnings last quarter?
TruBridge released its earnings results on May 08, 2026. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of N/A by $0.03.
Is TruBridge overvalued?
According to Wall Street analysts TruBridge’s price is currently Undervalued.
Does TruBridge pay dividends?
TruBridge pays a Quarterly dividend of $0.1 which represents an annual dividend yield of N/A. See more information on TruBridge dividends here
What is TruBridge’s EPS estimate?
TruBridge’s EPS estimate is 0.57.
How many shares outstanding does TruBridge have?
TruBridge has 14,999,136 shares outstanding.
What happened to TruBridge’s price movement after its last earnings report?
TruBridge reported an EPS of $0.03 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.232%.
Which hedge fund is a major shareholder of TruBridge?
Currently, no hedge funds are holding shares in TBRG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TruBridge Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$23.95 (3.01% Upside)
$23.95 (3.01% Upside)
Blogger Sentiment
Bullish
TBRG Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 23.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
49.61%
12-Months-Change
Fundamentals
Return on Equity
2.48%
Trailing 12-Months
Asset Growth
4.81%
Trailing 12-Months
Company Description
TruBridge
TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally. Its operations are structured around three core divisions: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement. The company places a strong emphasis on its RCM offerings, which are designed to integrate seamlessly with any primary healthcare information solutions provider. These offerings are complemented by business management, consulting, managed IT services, and sophisticated analytics and business intelligence tools. Its extensive RCM services span the entire revenue cycle, including patient liability estimates, eligibility verification, precise claim scrubbing and submission, remittance and denial/audit management, and contract management. Further capabilities include accounts receivable management, private pay services, medical coding, specialized revenue cycle consulting, and a range of additional insurance and patient billing services. TruBridge also provides specialized acute care solutions and associated services for community hospitals and physician clinics. Moreover, it leverages patient engagement and empowerment technologies to enhance patient outcomes and improve interaction strategies with care providers. Beyond these, the company offers general consulting and business management expertise, managed IT services, encoder solutions, patient management, financial accounting, and a suite of clinical, patient care, and enterprise applications. Its flagship TruBridge HER platform is a robust offering, encompassing total system support, access to national client conferences, continuing education resources, regular software releases, hardware replacement, and cloud-based electronic health record functionality, all built upon a secure public cloud infrastructure. Additionally, TruBridge supplies post-acute care software systems with comprehensive support and maintenance, alongside innovative tools like InstantPHR (an interactive patient portal) and CHBase, which efficiently centralizes data from diverse sources. Founded in 1979, the company recently underwent a rebranding from Computer Programs and Systems, Inc. to TruBridge, Inc. in March 2024. Its corporate headquarters are located in Mobile, Alabama.
TBRG Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized meaningful operational and financial progress — margin expansion, stronger cash generation, debt reduction, a growing and higher-quality pipeline, AI pilots showing early benefits, and strengthened financing and controls. Key challenges highlighted included modest top-line growth, Patient Care revenue pressures from a product sunset and mix, retention impacts from global workforce transition, prior-period accounting adjustments that delayed filings, and uncertainty from an ongoing strategic review. Overall, management presented a confident operational improvement narrative but acknowledged short-term conversion and visibility risks.View all TBRG earnings summariesTBRG Stock 12 Month Forecast
Average Price Target
$23.95
▲(3.01% Upside)
Technical Analysis
Ownership Overview
22.78% Insiders
13.95% Mutual Funds
13.25% Other Institutional Investors
39.68% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---